65,437 trials
Knee Osteoarthritis
Primary: Change From Baseline Osteoarthritis (OA) Pain in the Target Knee as Assessed by the Weekly Average of Daily Pain Numeric Rating Scale (NRS) — -2.77; -2.93; -2.43; -3.03…
Recurrent Colon Cancer · Recurrent Rectal Cancer · Stage IIA Colon Cancer
Primary: Maximum Standardized Uptake Value (SUVmax) in Physiologic Regions and Fluorodeoxyglucose (FDG) Avid Lesions in Participants Where PET-CT Was Performed Prior to the…
Hepatitis C, Chronic
Primary: SVR12 — 26; 30; 17 Participants
Prostate Cancer
Primary: Localizing Tumors — 128; 64 Areas of the body
Procedural Pain
Primary: Neonate Infant Pain Scale Score — 0; 1; 4; 4 score on a scale — p=<0.001
Liver Metastases From Colorectal Primary Cancer
Primary: Clinical Utility of Intraoperative Contrast Ultrasound in the Surgery of Colorectal Cancer Liver Metastases. — 7.7 percentage of patients
Chronic Sinusitis With Nasal Polyps and Eosinophilia
Primary: Ratio to Baseline in Peripheral Blood Eosinophil Counts After 6 Months of Treatment — 0.06 ratio to baseline — p=< 0.001
Peripheral Arterial Occlusive Disease
Primary: Procedural Success of Endovascular PAD Treatment(s) — 83.6; 75.8; 68.5 percent of procedures
Mental Health Wellness 1
Primary: Phone Retention — 9; 15; 14; 9 Participants — p=0.15
Metabolic Diseases
Primary: Brown Adipose Tissue Activation Following Glucagon or Saline Infusion — 0.074; 0.010; 0.029 MR[gluc] umol/kg/min — p=<0.01
Visual Acuity
Primary: Vision Scores — 59.38; 56.19 Units on a Scale
Short Duration Lower Limb Surgery Via Spinal Anaesthesia
Primary: Time to Regression of Spinal Block — 40.8; 39.4; 41.5 minutes
Neoplasms
Primary: Part 1: Number of Participants With Any Serious Adverse Event (SAE) and Non-serious Adverse Event (Non-SAE) — 1; 0; 3; 7 Participants
Healthy
Primary: Area Under the Plasma Concentration-time Curve From Time Zero to Infinity(AUC0-∞) of Unchanged MT-6548 — 105.3; 100.2; 129.3; 49.2 ug*h/mL
Nontuberculous Mycobacterium Infection
Primary: Percent Patients With Negative Sputum Culture — 40 percentage of participants